Decheng Capital LLC Aura Biosciences, Inc. Transaction History
Decheng Capital LLC
- $326 Billion
- Q2 2024
A detailed history of Decheng Capital LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 515,555 shares of AURA stock, worth $5.38 Million. This represents 1.19% of its overall portfolio holdings.
Number of Shares
515,555
Previous 515,555
-0.0%
Holding current value
$5.38 Million
Previous $4.05 Billion
3.69%
% of portfolio
1.19%
Previous 0.54%
Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
78Shares Held
40.3MCall Options Held
800Put Options Held
1.8K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$72.3 Million0.4% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$60.6 Million0.77% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.89MShares$51 Million0.07% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$31.7 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$31.4 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $306M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...